MentalHealthDaily

SPP1 Marks Cross-Disease Microglial Activation in Neurodegeneration

by GLOOM

MHD featured image for SPP1 microglia and neurodegeneration transcriptomics.

A 2026 Glia analysis found a shared microglial transcriptional program across 5 neurodegenerative contexts: ALS, frontotemporal dementia, Alzheimer’s disease, aging, and Parkinson’s disease.1 The standout marker was SPP1, a gene encoding osteopontin, but the finding is a cellular-state signal rather than a ready diagnostic test. Research Highlights Cross-disease microglia converged: the integrated dataset covered ALS, …

Lecanemab Clears Amyloid via Microglia and Fc Receptors

by GLOOM

Photoreal illustration of microglia clustering around an amyloid plaque, conveying immune-mediated clearance mechanism.

A 2026 Nature Neuroscience study found that lecanemab cleared amyloid in a humanized-microglia Alzheimer’s disease model only when microglia and the antibody’s intact Fc fragment were both present: X-34 plaque area differed across IgG1, lecanemab, and Fc-silenced LALA-PG groups (P = 0.0003), 82E1 plaque area differed across groups (P < 0.0001), and microglia-deficient mice showed …